1. Home
  2. KURA vs PDFS Comparison

KURA vs PDFS Comparison

Compare KURA & PDFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • PDFS
  • Stock Information
  • Founded
  • KURA 2014
  • PDFS 1992
  • Country
  • KURA United States
  • PDFS United States
  • Employees
  • KURA N/A
  • PDFS N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • PDFS EDP Services
  • Sector
  • KURA Health Care
  • PDFS Technology
  • Exchange
  • KURA Nasdaq
  • PDFS Nasdaq
  • Market Cap
  • KURA 793.2M
  • PDFS 1.1B
  • IPO Year
  • KURA N/A
  • PDFS N/A
  • Fundamental
  • Price
  • KURA $7.26
  • PDFS $27.16
  • Analyst Decision
  • KURA Strong Buy
  • PDFS Strong Buy
  • Analyst Count
  • KURA 11
  • PDFS 3
  • Target Price
  • KURA $27.89
  • PDFS $42.33
  • AVG Volume (30 Days)
  • KURA 1.8M
  • PDFS 153.4K
  • Earning Date
  • KURA 02-25-2025
  • PDFS 02-13-2025
  • Dividend Yield
  • KURA N/A
  • PDFS N/A
  • EPS Growth
  • KURA N/A
  • PDFS 56.69
  • EPS
  • KURA N/A
  • PDFS 0.11
  • Revenue
  • KURA N/A
  • PDFS $170,505,000.00
  • Revenue This Year
  • KURA N/A
  • PDFS $10.26
  • Revenue Next Year
  • KURA $233.30
  • PDFS $20.06
  • P/E Ratio
  • KURA N/A
  • PDFS $244.91
  • Revenue Growth
  • KURA N/A
  • PDFS 3.19
  • 52 Week Low
  • KURA $6.98
  • PDFS $26.60
  • 52 Week High
  • KURA $24.17
  • PDFS $39.70
  • Technical
  • Relative Strength Index (RSI)
  • KURA 17.38
  • PDFS 38.89
  • Support Level
  • KURA $6.98
  • PDFS $26.60
  • Resistance Level
  • KURA $8.88
  • PDFS $29.50
  • Average True Range (ATR)
  • KURA 0.33
  • PDFS 0.78
  • MACD
  • KURA 0.05
  • PDFS -0.06
  • Stochastic Oscillator
  • KURA 13.40
  • PDFS 19.31

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About PDFS PDF Solutions Inc.

PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.

Share on Social Networks: